Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	18.24	72.66	61.45
Graham Fair Price	2.29	21.70	21.21
PEG	204.78	-15.48	5.08
Price/Book	11.37	8.68	7.79
Price/Cash Flow	719.93	462.80	56.44
Prices/Earnings	21.74	45.08	37.03
Price/Sales	41.76	13.12	9.26
Price/FCF	719.93	462.80	56.44
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.29	0.49	0.46
Operating Margin	41.94	0.11	0.08
ROA	-2.39	0.02	0.02
ROE	0.05	0.05	-8.52
ROIC	0.03	0.04	51.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.13	-0.01	1229.04
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.14	0.20	37.59
EPS QOQ	0.07	-0.03	-60.06
FCF QOQ	2.19	-0.85	-61.00
Revenue QOQ	0.19	-0.16	-16.53
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	32.40	38.59	19.12
Days Sales Outstanding (DSO)	27.40	29.70	8.37
Inventory Turnover	2.78	2.33	-16.05
Debt/Capitalization	0.43	0.26	-39.71
Quick Ratio	0.84	0.87	3.01
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.49	20.85	6.94
Cash	8.43	8.23	-2.33
Capex	-1.41	-1.44	-1.95
Free Cash Flow	2.69	0.39	-85.47
Revenue	16.41	13.79	-15.98
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.05	1.07	2.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.32	2.98	28.43
Naive Interpretation	Member

06 - Financial Health · Bad

Rating